What is the equity of P&K Skin Research Center Co this year?
P&K Skin Research Center Co has equity of 70.81 B KRW this year.
In 2024, P&K Skin Research Center Co's equity was 70.81 B KRW, a 12.27% increase from the 63.07 B KRW equity in the previous year.
P&K Skin Research Center Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding P&K Skin Research Center Co's equity is essential for assessing its financial health, stability, and value to shareholders.
Evaluating P&K Skin Research Center Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
P&K Skin Research Center Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Fluctuations in P&K Skin Research Center Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
P&K Skin Research Center Co has equity of 70.81 B KRW this year.
The equity of P&K Skin Research Center Co has increased/decreased by 12.27% increased compared to the previous year.
A high equity is advantageous for investors of P&K Skin Research Center Co as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
A low equity can be a risk for investors of P&K Skin Research Center Co, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
An increase in equity of P&K Skin Research Center Co can strengthen the company's financial position and improve its ability to make investments in the future.
A reduction in equity of P&K Skin Research Center Co can affect the financial situation of the company and lead to a higher dependence on debt capital.
Some factors that can affect the equity of P&K Skin Research Center Co include profits, dividend payments, capital increases, and acquisitions.
The equity of P&K Skin Research Center Co is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
To change equity, P&K Skin Research Center Co can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
Over the past 12 months, P&K Skin Research Center Co paid a dividend of 35 KRW . This corresponds to a dividend yield of about 1.08 %. For the coming 12 months, P&K Skin Research Center Co is expected to pay a dividend of 35 KRW.
The current dividend yield of P&K Skin Research Center Co is 1.08 %.
P&K Skin Research Center Co pays a quarterly dividend. This is distributed in the months of .
P&K Skin Research Center Co paid dividends every year for the past 2 years.
For the upcoming 12 months, dividends amounting to 35 KRW are expected. This corresponds to a dividend yield of 1.08 %.
P&K Skin Research Center Co is assigned to the 'Health' sector.
To receive the latest dividend of P&K Skin Research Center Co from 4/19/2024 amounting to 30 KRW, you needed to have the stock in your portfolio before the ex-date on 12/27/2023.
The last dividend was paid out on 4/19/2024.
In the year 2023, P&K Skin Research Center Co distributed 37.5 KRW as dividends.
The dividends of P&K Skin Research Center Co are distributed in KRW.
Our stock analysis for P&K Skin Research Center Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of P&K Skin Research Center Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.